Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis

We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reaso...

Descripción completa

Detalles Bibliográficos
Autores principales: Artru, Florent, Alberio, Lorenzo, Moradpour, Darius, Stalder, Grégoire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Unusual Association of Diseases/Symptoms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342180/
https://www.ncbi.nlm.nih.gov/pubmed/32641442
http://dx.doi.org/10.1136/bcr-2020-236815
Descripción
Sumario:We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reasonable to evoke ITP in case of profound thrombocytopaenia in a patient with COVID-19.

Ejemplares similares